BCL-2 inhibitorscheckpoint inhibitorsmonoclonal antibodiesmelanomabreasthaematologic malignancieslungcolorectal cancersgynaecologic
…e inhibitors, epigenetic modifiers and apoptosis promoters (eg, BCL-2 inhibitors). Despite their growing use, these therapies are poorly studied…